$REGN
REGENERON PHARMACEUTICALS, INC.

2021 Q2 Form 10-Q Financial Statement

#000180422021000025 Filed on August 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $5.139B $1.952B
YoY Change 163.24% 23.72%
Cost Of Revenue $693.7M $275.5M
YoY Change 151.8% 88.96%
Gross Profit $4.445B $1.677B
YoY Change 165.12% 17.07%
Gross Profit Margin 86.5% 85.89%
Selling, General & Admin $414.7M $348.3M
YoY Change 19.06% 18.23%
% of Gross Profit 9.33% 20.78%
Research & Development $714.2M $722.0M
YoY Change -1.08% -18.46%
% of Gross Profit 16.07% 43.07%
Depreciation & Amortization $71.10M $58.80M
YoY Change 20.92% 12.86%
% of Gross Profit 1.6% 3.51%
Operating Expenses $1.129B $1.070B
YoY Change 5.48% -9.3%
Operating Profit $3.347B $656.4M
YoY Change 409.93% 107.98%
Interest Expense $14.40M $9.700M
YoY Change 48.45% 21.25%
% of Operating Profit 0.43% 1.48%
Other Income/Expense, Net $405.6M $262.5M
YoY Change 54.51% -388.78%
Pretax Income $3.753B $918.9M
YoY Change 308.4% 308.95%
Income Tax $653.9M $21.60M
% Of Pretax Income 17.42% 2.35%
Net Earnings $3.099B $897.3M
YoY Change 245.36% 364.68%
Net Earnings / Revenue 60.31% 45.97%
Basic Earnings Per Share $29.51 $8.19
Diluted Earnings Per Share $27.97 $7.61
COMMON SHARES
Basic Shares Outstanding 105.0M shares 109.6M shares
Diluted Shares Outstanding 110.8M shares 117.9M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.911B $3.144B
YoY Change 24.39% 17.75%
Cash & Equivalents $2.072B $1.992B
Short-Term Investments $1.839B $1.152B
Other Short-Term Assets $444.3M $770.0M
YoY Change -42.3% 28.76%
Inventory $1.984B $1.641B
Prepaid Expenses
Receivables $6.999B $1.991B
Other Receivables $0.00 $0.00
Total Short-Term Assets $13.34B $7.860B
YoY Change 69.69% 18.18%
LONG-TERM ASSETS
Property, Plant & Equipment $3.359B $3.031B
YoY Change 10.79% 13.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.940B $2.658B
YoY Change 48.24% -7.87%
Other Assets $142.9M $175.5M
YoY Change -18.58% 25.54%
Total Long-Term Assets $8.148B $6.569B
YoY Change 24.05% 0.7%
TOTAL ASSETS
Total Short-Term Assets $13.34B $7.860B
Total Long-Term Assets $8.148B $6.569B
Total Assets $21.49B $14.43B
YoY Change 48.91% 9.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $476.0M $380.0M
YoY Change 25.26% 55.74%
Accrued Expenses $2.018B $1.257B
YoY Change 60.54% 43.33%
Deferred Revenue $520.0M
YoY Change
Short-Term Debt $0.00 $1.500B
YoY Change -100.0%
Long-Term Debt Due $718.4M
YoY Change
Total Short-Term Liabilities $3.732B $3.702B
YoY Change 0.81% 116.12%
LONG-TERM LIABILITIES
Long-Term Debt $1.979B $716.0M
YoY Change 176.42% 0.7%
Other Long-Term Liabilities $596.3M $457.9M
YoY Change 30.22% 70.92%
Total Long-Term Liabilities $2.576B $457.9M
YoY Change 462.46% 70.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.732B $3.702B
Total Long-Term Liabilities $2.576B $457.9M
Total Liabilities $6.359B $5.371B
YoY Change 18.38% 57.16%
SHAREHOLDERS EQUITY
Retained Earnings $15.11B $8.902B
YoY Change 69.71% 50.41%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.221B $6.143B
YoY Change 17.56% 1290.43%
Treasury Stock Shares 17.66M shares 15.58M shares
Shareholders Equity $15.13B $9.057B
YoY Change
Total Liabilities & Shareholders Equity $21.49B $14.43B
YoY Change 48.91% 9.53%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $3.099B $897.3M
YoY Change 245.36% 364.68%
Depreciation, Depletion And Amortization $71.10M $58.80M
YoY Change 20.92% 12.86%
Cash From Operating Activities $626.7M $943.4M
YoY Change -33.57% 401.01%
INVESTING ACTIVITIES
Capital Expenditures -$148.5M -$129.9M
YoY Change 14.32% 37.32%
Acquisitions
YoY Change
Other Investing Activities $274.3M $1.583B
YoY Change -82.68% -313.56%
Cash From Investing Activities $125.8M $1.453B
YoY Change -91.34% -273.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -118.2M -2.613B
YoY Change -95.48% 16977.12%
NET CHANGE
Cash From Operating Activities 626.7M 943.4M
Cash From Investing Activities 125.8M 1.453B
Cash From Financing Activities -118.2M -2.613B
Net Change In Cash 634.3M -216.0M
YoY Change -393.66% -67.42%
FREE CASH FLOW
Cash From Operating Activities $626.7M $943.4M
Capital Expenditures -$148.5M -$129.9M
Free Cash Flow $775.2M $1.073B
YoY Change -27.77% 279.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000872589
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Small Business
EntitySmallBusiness
false
dei Entity File Number
EntityFileNumber
0-19034
dei Entity Registrant Name
EntityRegistrantName
REGENERON PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3444607
dei Entity Address Address Line1
EntityAddressAddressLine1
777 Old Saw Mill River Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591-6707
dei City Area Code
CityAreaCode
914
dei Local Phone Number
LocalPhoneNumber
847-7000
dei Security12b Title
Security12bTitle
Common Stock - par value $.001 per share
dei Trading Symbol
TradingSymbol
REGN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2072200000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2193700000 USD
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1838600000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1393300000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6998600000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4114700000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
1983900000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1916600000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
444300000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
160800000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
13337600000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
9779100000 USD
CY2021Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3900300000 USD
CY2020Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3135600000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3358500000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3221600000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
746600000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
858900000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
142900000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
168100000 USD
CY2021Q2 us-gaap Assets
Assets
21485900000 USD
CY2020Q4 us-gaap Assets
Assets
17163300000 USD
CY2021Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
476000000.0 USD
CY2020Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
475500000 USD
CY2021Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2018000000.0 USD
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1644200000 USD
CY2021Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
718400000 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
520000000.0 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
577700000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21485900000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17163300000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11025300000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3732400000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2697400000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1979200000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1978500000 USD
CY2021Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
717200000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
50700000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
57800000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
596300000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
687100000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
6358600000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
6138000000.0 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5138500000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
15127300000 USD
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7225800000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6716200000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15107100000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10893000000.0 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15700000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
29300000 USD
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
17656256 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
16431520 shares
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
7221400000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
6613300000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1952000000.0 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7667200000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3780200000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
714200000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
722000000.0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1457100000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1305900000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
414700000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
348300000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
820300000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
715600000 USD
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
31300000 USD
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
50200000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
71800000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
90600000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
1791300000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
1295600000 USD
us-gaap Costs And Expenses
CostsAndExpenses
3207300000 USD
us-gaap Costs And Expenses
CostsAndExpenses
2423700000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3347200000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
656400000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4459900000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1356500000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
420000000.0 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
272200000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
574900000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
246800000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
14400000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
9700000 USD
us-gaap Interest Expense
InterestExpense
29000000.0 USD
us-gaap Interest Expense
InterestExpense
15800000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
405600000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
262500000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
545900000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
231000000.0 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3752800000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
918900000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5005800000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1587500000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
653900000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
791700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65600000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
3098900000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
897300000 USD
us-gaap Net Income Loss
NetIncomeLoss
4214100000 USD
us-gaap Net Income Loss
NetIncomeLoss
1521900000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
29.51
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
40.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
13.87
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
27.97
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
38.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
13.03
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105000000.0 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109700000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110800000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117900000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116800000 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
3098900000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
897300000 USD
us-gaap Net Income Loss
NetIncomeLoss
4214100000 USD
us-gaap Net Income Loss
NetIncomeLoss
1521900000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-800000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
44600000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14100000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
15800000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
300000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
500000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1400000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3098400000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
941900000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4200500000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1536300000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11025300000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
93900000 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
66400000 USD
CY2021Q1 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
10000000.0 USD
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
323500000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
135600000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1115200000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13100000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11977000000.0 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
216600000 USD
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
26100000 USD
CY2021Q2 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
14100000 USD
CY2021Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
288600000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
135900000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
3098900000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-500000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
15127300000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11089700000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
817400000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
155100000 USD
CY2020Q1 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
14600000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
336000000.0 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
108000000.0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
624600000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-30200000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
12133000000.0 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1355500000 USD
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
416500000 USD
CY2020Q2 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
10100000 USD
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5071800000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
105200000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
897300000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
44600000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
9057400000 USD
us-gaap Net Income Loss
NetIncomeLoss
4214100000 USD
us-gaap Net Income Loss
NetIncomeLoss
1521900000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
138500000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
114900000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
276400000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
209300000 USD
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
553900000 USD
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
199600000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-192600000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-23800000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-51800000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-118000000.0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2883900000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
47100000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
221500000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
233400000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
277800000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-33800000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-64800000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
78900000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
423700000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
20900000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-2918900000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
119500000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1295200000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1641400000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1886500000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1533500000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1217100000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2843700000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
263800000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
300000000.0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-933200000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1010200000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1500000000.0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
308200000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2168000000.0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
180700000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
571600000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
612100000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5373600000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-484600000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2277200000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-122600000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
374400000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2207300000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1630300000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2084700000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2004700000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
3098900000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
897300000 USD
us-gaap Net Income Loss
NetIncomeLoss
4214100000 USD
us-gaap Net Income Loss
NetIncomeLoss
1521900000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105000000.0 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109700000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110800000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117900000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116800000 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
29.51
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
40.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
13.87
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
27.97
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
38.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
13.03
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4315500000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
25800000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3700000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4337600000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3649200000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
40100000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
200000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3689100000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1838600000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1393300000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2499000000.0 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2295800000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4337600000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3689100000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1311700000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
3700000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1311700000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
3700000 USD
CY2021Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2020Q2 regn Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
28000000.0 USD
regn Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
28300000 USD
CY2020Q2 regn Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
0 USD
regn Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
0 USD
CY2021Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
409000000.0 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
552900000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
228100000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
171300000 USD
CY2021Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
40000000.0 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
59200000 USD
CY2021Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1868000000 USD
CY2020Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1958000000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
601500000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
459400000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
741100000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
904600000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
106300000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
121700000 USD
CY2021Q2 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
535000000.0 USD
CY2020Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
430900000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
1983900000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1916600000 USD
CY2021Q2 us-gaap Inventory Write Down
InventoryWriteDown
139900000 USD
us-gaap Inventory Write Down
InventoryWriteDown
149300000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2020Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.174
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.024
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.158
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.041
CY2021Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
600000 shares
CY2020Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1300000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
700000 shares
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
288600000 USD
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
612100000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
272800000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2072200000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1992200000 USD
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2084700000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2004700000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
93400000 USD
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
83600000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
87400000 USD
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
133700000 USD

Files In Submission

Name View Source Status
0001804220-21-000025-index-headers.html Edgar Link pending
0001804220-21-000025-index.html Edgar Link pending
0001804220-21-000025.txt Edgar Link pending
0001804220-21-000025-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
regn-20210630.htm Edgar Link pending
regn-20210630.xsd Edgar Link pending
regn-20210630_cal.xml Edgar Link unprocessable
regn-20210630_def.xml Edgar Link unprocessable
regn-20210630_htm.xml Edgar Link completed
regn-20210630_lab.xml Edgar Link unprocessable
regn-20210630_pre.xml Edgar Link unprocessable
regn-ex_311x06302021x10q.htm Edgar Link pending
regn-ex_312x06302021x10q.htm Edgar Link pending
regn-ex_32x06302021x10q.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending